Back to VA VANGUARD CAPITAL MANAGEMENT LLC
BNGO2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in BIONANO GENOMICS INC
Yes. Vanguard Capital Management holds 82,388 shares of BNGO (Bionano Genomics), worth $93,098, as of its Q2 2026 13F filing. It increased the position by 14,279 shares (+21.0%) from Q1 2026. Vanguard Capital Management has held BNGO in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$93,098
Current Shares
82,388
Total Value Change
+$13,410
Total Shares Change
+14,279
Quarter-by-Quarter History
Other major holders of BNGO: GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, UBS Group AG